Hong Liang

机构：National University of Singapore, Guangxi Normal University, Minjiang University, Nanjing University of Science and Technology, National University Cancer Institute, Singapore, Fuzhou University · ORCID：0000-0002-1979-2509

发表论文 191 篇 · 总被引 5218 次 · h-index 42

代表论文

• Oxoisoaporphine Alkaloid Iridium(III) Derivative: An Immunogenic Cell Death Inducer That Engages the Autophagy-Dependent Regulator Cathepsin D (2025 · Journal of the American Chemical Society · 被引 37)
• Design of a theranostic Gd (III)–Cu (I) complex to inhibit growth and metastasis of triple‐negative breast cancer (2025 · Rare Metals · 被引 19)
• Copper(II) Complexes of Pyrazolopyrimidine Derivatives as Anticancer Agents with Enhanced Chemodynamic Therapy through Bimodal Apoptosis and Ferroptosis (2025 · Journal of Medicinal Chemistry · 被引 18)
• A Smart mRNA‐Initiated Theranostic Multi‐shRNA Nanofactory for Precise and Efficient Cancer Gene Therapy (2025 · Advanced Healthcare Materials · 被引 7)
• In vitro and in vivo studies on three new 8-hydroxyquinoline-based zinc(II) coordination compounds as potential antimelanoma cancer agents (2025 · Bioorganic Chemistry · 被引 4)
• Nanopores‐coupled SERS platforms on superslippery surfaces using Au&Ag alloy pillars for biomolecules enrichment and detection (2025 · Rare Metals · 被引 3)